In this article, we explore how cold-chain logistics are evolving to support the unique demands of the pharmaceutical industry. From precision temperature control and proactive compliance management to real-time visibility and mission-critical support systems, discover the strategies that help ensure safe, reliable delivery of temperature-sensitive medicines. Featuring insights into emerging expectations for traceability, rapid response protocols, and customized logistics solutions, this piece highlights how best-in-class cold-chain practices build resilience and protect product integrity.
FDA reportedly shelves its Commissioner’s National Priority Voucher program, Eli Lilly breaks ground on a $3.5 billion Pennsylvania manufacturing site for next-generation obesity treatments, and Parexel’s Stacy Hurt on how small protocol decisions can become enrollment and retention barriers.
Every protocol decision affects patients, and only those with lived disease experience can identify true burden — from invasive biopsies to daily trial demands.
Moderna lays out an oncology-driven growth plan at its 2026 Analyst Day, Pfizer and Blackstone sign a co-funding deal worth up to $1.5 billion for berobenatide, and Parexel’s Stacy Hurt on how patients’ use of AI is reshaping sponsor communication.
Pfizer and Blackstone Life Sciences sign a co-funding deal in which Blackstone is set to provide up to $1.5 billion through 2028 to advance berobenatide.
